MicuRx Pharmaceuticals Highlights Pipeline Progress for MRX-5 and MRX-8 at BIO Investor Forum

SAN FRANCISCO, Oct. 18, 2024 — Dr. Regis Vilchez, Chief Medical Officer of MicuRx Pharmaceuticals, presented the latest advancements of the company's development program, MRX-5 and MRX-8, at the BIO Investor Forum (BIF). These development programs offer new potentials for the future treatment of Nontuberculous Mycobacterial (NTM) pulmonary diseases and Pseudomonas…

Accord Healthcare’s Biosimilar to Stelara® Receives Positive CHMP Opinion

Accord announces that the CHMP has issued a positive opinion for Imuldosa® (development code: DMB-3115), a biosimilar to Stelara®, indicated for a range of immunology conditions. The approval of Imuldosa® further enhances Accord Healthcare’s biosimilar portfolio and strengthens Accord’s Autoimmune Franchise building on existing leading brands. Imuldosa® will be the 5th biosimilar for…

Foreign Journalists and Bloggers Explore the “Pearl of Western Jiangxi”

PINGXIANG, China, Oct. 19, 2024 — A report from Jiangxi International Communication Center(JXICC): Recently, a group of foreign journalists and bloggers from seven countries including the UK, Japan, South Korea, and Indonesia visited Pingxiang in Jiangxi Province. They explored Pingxiang's cultural heritage and witnessed the stunning natural beauty of Wugong Mountain. Pingxiang,…

Moolec Has Received USDA Approval for the First Genetically Modified Pea in History

Luxembourg, Oct 16, 2024 - (ACN Newswire via SeaPRwire.com) - Moolec Science SA (NASDAQ:MLEC) ("the Company"), a leader in Molecular Farming technology, announced today that the U.S. Department of Agriculture's ("USDA") Animal and Plant Health Inspection Service ("APHIS") has completed its Regulatory Status Review ("RSR") for the Company's genetically engineered ("GE")…

CITIC Telecom CPC Propels ‘+AI to AI+’

HONG KONG, Oct 18, 2024 - (ACN Newswire via SeaPRwire.com) - CITIC Telecom International CPC Limited (“CITIC Telecom CPC”), a wholly-owned subsidiary of CITIC Telecom International Holdings Limited (SEHK: 1883) is at the forefront of AI+ innovation era, enabling dual empowerment of technology and data, and fostering a new business model…